A curated wound management feed spanning chronic wound recovery, burn management, and diabetic ulcer interventions.
Annotation: Day 0 vs. Day 21, annotated wound boundary overlay showing 34% reduction in surface area.
A 68-year-old immobilized patient presented with a sacral Stage IV ulcer refractory to 14 weeks of standard moist-wound therapy. Clinicians initiated a Conexeu bioactive matrix regimen with weekly debridement and quantitative wound imaging.
By day 21, granulation tissue coverage exceeded 82% and mean closure velocity outpaced the matched control cohort by 34%. Full epithelialization was documented at day 63, without recurrence at the six-month follow-up.
Four dispatch streams tracking the science, the protocols, and the outcomes shaping chronic wound therapy today.
Advanced dressing science: growth factors, collagen matrices, and next-generation bioactive wound interfaces.
View CasesEvidence-based protocols for venous, arterial, and mixed-etiology ulcers across care settings.
View CasesStrategies for minimizing necrotic progression and optimizing viable tissue margins.
View CasesOutcome benchmarks, closure rate data, and time-to-heal analytics across wound types.
View CasesSix recent cases from the field, annotated by attending wound care specialists. Each entry pairs clinical documentation with a bedside pearl for practical reference.
Fig. 01, Plantar surface, MTH-1. Callus ring debrided, granulation base visible.
Total-contact offloading paired with a silver-alginate regimen achieved complete epithelial closure at six weeks post-intake.
Palpate pedal pulses before every dressing change, perfusion status changes faster than the wound bed.
Fig. 02, Partial-thickness, forearm. Biosynthetic sheet adherent, no purulence.
Biosynthetic covering trialed against standard silver sulfadiazine, yielding a measurable reduction in colonization and dressing-change frequency.
Resist the urge to lift a biosynthetic early, premature inspection breaks the seal you spent 48 hours forming.
Fig. 03, Medial gaiter zone. Ruler at 4.2cm × 3.1cm, day 14 measurement.
Structured adherence coaching around four-layer compression produced a 62% wound-area reduction by day 28 of therapy.
Periwound maceration noted, moisture barrier applied at every visit, compression fails first at the skin edge.
Fig. 04, Sacrum, Stage 3. Undermining at 2 o'clock, slough covering 40%.
A two-hour turning schedule audit combined with enzymatic debridement restored granulation within nineteen days on a previously stalled wound.
If turning documentation is perfect but the wound is not healing, the turns are not happening, audit the surface, not the chart.
Fig. 05, Lateral malleolus. Punched-out margins, eschar center, pale base.
Documents the vascular referral pathway used when calcified margins and ABI results contraindicated further local wound intervention.
A dry, stable eschar over an ischemic limb is a dressing, not a failure, do not debride until perfusion is restored.
Fig. 06, Midline laparotomy. Black foam in situ, -125 mmHg continuous.
Negative pressure wound therapy protocol adopted at day three post-dehiscence, achieving granulation coverage sufficient for delayed primary closure.
If the canister fills faster than expected, look for a fistula before you look for a leak.
Cases sourced from contributing centers. Patient identifiers removed per HIPAA protocol.
Read the full dispatch archive
Expert Contributor Panel
Every case study and protocol note in this feed is authored or reviewed by certified wound care specialists, CWCN-credentialed nurses, and vascular medicine faculty. We bring direct bedside experience to every dispatch.
"We don't publish what we haven't seen at the bedside."
Standing Contributors
New case studies, Triage Spotlights, and bedside protocol updates, delivered when they matter.